Sources | Names Used |
---|---|
CTRPv2 | BRD-K02251932 |
PharmacoGx | BRD-K02251932 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRP9 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | SLC25A43 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
mRNA | USP34 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | RP11-47I22.4 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
mRNA | SF3A2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
mRNA | ZNF839 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
mRNA | SLC25A38 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |
mRNA | HLA-DRA | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
mRNA | MED6 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
mRNA | ZNF266 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.06 |